Post by Sanofi

The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has recommended for approval our new investigational treatment for secondary progressive multiple sclerosis (SPMS) without relapses.      Read our press release: https://lnkd.in/eVy4h-_8